share_log

Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(18.9%)

Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(18.9%)

Black Diamond Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. Rowe Price Investment Management, Inc.(18.9%)
美股SEC公告 ·  07/10 14:18
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息